BACH1 promotes lung cancer cell migration and invasion by inducing the expression of metabolic genes (such as HK2) leading to an increase in glycolysis [40], and thus BACH1 inhibitors have the potential to reduce the spread of lung cancer cells. The gene discussed is BACH1; the disease is lung carcinoma.